Found: 137
Select item for more details and to access through your institution.
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1732, doi. 10.1002/ajh.27383
- By:
- Publication type:
- Article
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core‐binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1290, doi. 10.1002/ajh.27342
- By:
- Publication type:
- Article
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 360, doi. 10.1002/ajh.27187
- By:
- Publication type:
- Article
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 580, doi. 10.1002/ajh.26825
- By:
- Publication type:
- Article
Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E41, doi. 10.1002/ajh.26782
- By:
- Publication type:
- Article
Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1065, doi. 10.1002/ajh.26627
- By:
- Publication type:
- Article
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
- By:
- Publication type:
- Article
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. 40, doi. 10.1002/ajh.26000
- By:
- Publication type:
- Article
Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1200, doi. 10.1002/ajh.25934
- By:
- Publication type:
- Article
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1135, doi. 10.1002/ajh.25905
- By:
- Publication type:
- Article
Impact of detectable measurable residual disease on umbilical cord blood transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1057, doi. 10.1002/ajh.25879
- By:
- Publication type:
- Article
CD34+ cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT)
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 892, doi. 10.1002/ajh.25826
- By:
- Publication type:
- Article
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 282, doi. 10.1002/ajh.25714
- By:
- Publication type:
- Article
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 431, doi. 10.1002/ajh.25395
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 2, p. 231, doi. 10.1002/ajh.25355
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1532, doi. 10.1002/ajh.25285
- By:
- Publication type:
- Article
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1236, doi. 10.1002/ajh.25231
- By:
- Publication type:
- Article
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1211, doi. 10.1002/ajh.25225
- By:
- Publication type:
- Article
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1142, doi. 10.1002/ajh.25211
- By:
- Publication type:
- Article
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 859, doi. 10.1002/ajh.25105
- By:
- Publication type:
- Article
Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 794, doi. 10.1002/ajh.25097
- By:
- Publication type:
- Article
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 778, doi. 10.1002/ajh.25091
- By:
- Publication type:
- Article
Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 769, doi. 10.1002/ajh.25087
- By:
- Publication type:
- Article
T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 736, doi. 10.1002/ajh.25082
- By:
- Publication type:
- Article
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 246, doi. 10.1002/ajh.24963
- By:
- Publication type:
- Article
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 31, doi. 10.1002/ajh.24928
- By:
- Publication type:
- Article
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1318, doi. 10.1002/ajh.24904
- By:
- Publication type:
- Article
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 997, doi. 10.1002/ajh.24823
- By:
- Publication type:
- Article
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 789, doi. 10.1002/ajh.24771
- By:
- Publication type:
- Article
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 653, doi. 10.1002/ajh.24737
- By:
- Publication type:
- Article
Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 429, doi. 10.1002/ajh.24677
- By:
- Publication type:
- Article
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 344, doi. 10.1002/ajh.24640
- By:
- Publication type:
- Article
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 18, doi. 10.1002/ajh.24567
- By:
- Publication type:
- Article
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party ( ALWP) of the European group of blood and marrow transplantation ( EBMT).
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 8, p. 719, doi. 10.1002/ajh.24069
- By:
- Publication type:
- Article
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 9, p. 1, doi. 10.1002/cti2.1171
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 2, p. 189, doi. 10.1177/1352458514541978
- By:
- Publication type:
- Article
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 10, p. 1392, doi. 10.1086/598324
- By:
- Publication type:
- Article
Competing risks regression for clustered data.
- Published in:
- Biostatistics, 2012, v. 13, n. 3, p. 371, doi. 10.1093/biostatistics/kxr032
- By:
- Publication type:
- Article
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 831, doi. 10.1016/j.clml.2021.07.010
- By:
- Publication type:
- Article
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01072-0
- By:
- Publication type:
- Article
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00990-3
- By:
- Publication type:
- Article
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00479-3
- By:
- Publication type:
- Article
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0296-3
- By:
- Publication type:
- Article
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0251-3
- By:
- Publication type:
- Article